Related Articles Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4. Oncol Lett. 2020 Nov;20(5):171 Authors: Chen F, Zhu L, Hu J, Jiang S, Liu H, Zheng J, Wang J, Wang F, Li Z Abstract Triple-negative breast cancer (TNBC) has the poorest prognosis among all types of breast cancer and there is yet no effective therapy. Chemotherapy is the traditional standard of care for patients with...
Thu Sep 17, 2020 13:02
Related Articles Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling. J Cell Mol Med. 2020 Sep 15;: Authors: Liao Y, Gao Y, Chang A, Li Z, Wang H, Cao J, Gu W, Tang R Abstract As a selective inhibitor of BRAF kinase, dabrafenib has shown potent anti-tumour activities in patients with BRAFV600E mutant anaplastic thyroid cancer. However, the resistance of thyroid...
Thu Sep 17, 2020 15:01
In vitro and In Vivo Immunomodulatory Activity of Physalis angulata Concentrated Ethanolic Extract. Planta Med. 2020 Sep 16;: Authors: Daltro SRT, Santos IP, Barros PL, Moreira DRM, Tomassini TCB, Ribeiro IM, Ribeiro Dos Santos R, Meira CS, Soares MBP Abstract The need for new immunomodulatory drugs is due to the side effects associated with the prolonged use of the currently used immunomodulatory drugs. In this context, the present work...
Thu Sep 17, 2020 13:02
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου